Mabwell Receives IND Clearance for Novel Anti-ST2 Monoclonal Antibody 9MW1911 to Initiate Phase IIa Study Written by PR Newswire Enable JavaScript and cookies to continueRead more http://www.prnasia.com/story/archive/4853507_CN53507_0